Accupril and Lichen planus aggravated - a phase IV clinical study of FDA data

Summary:

Lichen planus aggravated is reported as a side effect among people who take Accupril (quinapril hydrochloride), especially for people who are male, 40-49 old, also take Norvasc, and have Gastritis.

The phase IV clinical study analyzes which people have Lichen planus aggravated when taking Accupril. It is created by eHealthMe based on reports of 13,164 people who have side effects when taking Accupril from the FDA, and is updated regularly.

What is Accupril?

Accupril has active ingredients of quinapril hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 13,404 Accupril users. Check the latest studies of Accupril.

What is Lichen planus aggravated?

Lichen planus aggravated (a inflammatory skin condition, characterized by an itchy, non-infectious rash) is found to be associated with 284 drugs and 325 conditions by eHealthMe. Check the latest studies of Lichen planus aggravated.

On Jul, 20, 2026

13,164 people reported to have side effects when taking Accupril.
Among them, 19 people (0.14%) have Lichen planus aggravated.

Could Accupril cause Lichen planus aggravated?

Among these 19 people:

What is the gender of people who have Lichen planus aggravated when taking Accupril? *

female: 21.05 %
male: 78.95 %

What is the age of people who have Lichen planus aggravated when taking Accupril? *

What are other drugs people take besides Accupril? *

What are other side effects people have besides Lichen planus aggravated? *

Stress And Anxiety: 15 people, 78.95%
Pain In Extremity: 15 people, 78.95%
Osteomyelitis (infection of bone): 15 people, 78.95%
Bone Disorder: 15 people, 78.95%
Oral Herpes (viral infection of mouth): 15 people, 78.95%
Bone Pain: 15 people, 78.95%
Sinus Disorder (disease of sinus): 15 people, 78.95%
Mouth Ulcers: 15 people, 78.95%
Cellulitis (infection under the skin): 15 people, 78.95%
Back Pain: 15 people, 78.95%

What are the existing conditions these people have? *

Sinus Congestion (blockage of sinus): 2 people, 10.53%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 10.53%
Osteopenia (a condition where bone mineral density is lower than normal): 2 people, 10.53%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 2 people, 10.53%
Gastritis (inflammation of stomach): 2 people, 10.53%
Osteoporosis (bones weak and more likely to break): 1 person, 5.26%
Bone Loss: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Accupril and have Lichen planus aggravated?

- Check whether Lichen planus aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Accupril:

Accupril (13,404 reports)

Browse all side effects of Accupril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lichen planus aggravated:

Lichen planus aggravated (284 drugs)

Browse all the conditions that are associated with Lichen planus aggravated:

Lichen planus aggravated (325 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on quinapril hydrochloride (the active ingredients of Accupril) and Accupril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.